Zhiyong Zeng

5PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 15, 2026
Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.

|Aug 11, 2026
Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study.

|Apr 26, 2026
Multicenter Real-World Analysis of Glofitamab in Relapsed/Refractory Primary CNS Lymphoma: Clinical Activity, CNS Penetration, and ctDNA Dynamics.

|Jul 13, 2025
B4GALT3 as a Key Glycosyltransferase Gene in Multiple Myeloma Progression: Insights From Bioinformatics, Machine Learning, and Experimental Validation.

Apeng Yang, Mengying Ke, Lin Feng

|Sep 28, 2021
Pathophysiological role of calcium channels and transporters in the multiple myeloma.

Tingting Li, Junmin Chen, Zhiyong Zeng

Pageof 1

Frequent Collaborators

2 joint publications

Qincheng Che

2 joint publications

Apeng Yang

1 joint publications

Hui Liu

1 joint publications

Qingjiao Chen